Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Nutrien
NTR
|
+$111M |
| 2 |
WP
Worldpay, Inc.
WP
|
+$37.6M |
| 3 |
Becton Dickinson
BDX
|
+$29.5M |
| 4 |
Alibaba
BABA
|
+$28.3M |
| 5 |
NXP Semiconductors
NXPI
|
+$24.5M |
Top Sells
| 1 |
Apple
AAPL
|
+$431M |
| 2 |
Microsoft
MSFT
|
+$315M |
| 3 |
Amazon
AMZN
|
+$278M |
| 4 |
Meta Platforms (Facebook)
META
|
+$170M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$150M |
Sector Composition
| 1 | Technology | 19.03% |
| 2 | Healthcare | 14.49% |
| 3 | Consumer Discretionary | 11.53% |
| 4 | Industrials | 10.4% |
| 5 | Communication Services | 10.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PMT
1601
PennyMac Mortgage Investment
PMT
$1.07B
| $2.1M | ﹤0.01% |
116,200
+3,500
| +3% | +$63.1K |
|
|
AFSI
1602
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $2.09M | ﹤0.01% |
169,980
+3,200
| +2% | +$39.4K |
|
1603
Mativ Holdings
MATV
$674M
| $2.09M | ﹤0.01% |
53,400
+1,100
| +2% | +$43.1K |
|
|
INST
1604
DELISTED
Instructure, Inc.
INST
| $2.09M | ﹤0.01% |
49,600
+26,700
| +117% | +$1.13M |
|
1605
Dillards
DDS
$9.02B
| $2.09M | ﹤0.01% |
26,000
+400
| +2% | +$32.1K |
|
1606
Iovance Biotherapeutics
IOVA
$836M
| $2.09M | ﹤0.01% |
123,600
+19,000
| +18% | +$321K |
|
1607
SiriusPoint
SPNT
$2.22B
| $2.09M | ﹤0.01% |
149,700
+2,700
| +2% | +$37.7K |
|
1608
Diodes
DIOD
$2.46B
| $2.09M | ﹤0.01% |
68,500
| – | – |
|
1609
Cannae Holdings
CNNE
$1.12B
| $2.08M | ﹤0.01% |
110,494
+1,900
| +2% | +$35.8K |
|
|
ENDP
1610
DELISTED
Endo International plc
ENDP
| $2.08M | ﹤0.01% |
349,900
+13,100
| +4% | +$77.8K |
|
1611
Piper Sandler
PIPR
$6.13B
| $2.08M | ﹤0.01% |
25,000
| – | – |
|
1612
Steelcase
SCS
$1.93B
| $2.08M | ﹤0.01% |
152,600
| – | – |
|
1613
Antero Midstream
AM
$8.92B
| $2.07M | ﹤0.01% |
129,600
+66,100
| +104% | +$1.06M |
|
|
RWT
1614
Redwood Trust
RWT
$810M
| $2.07M | ﹤0.01% |
133,800
+2,500
| +2% | +$38.7K |
|
1615
Dynavax Technologies
DVAX
$1.1B
| $2.07M | ﹤0.01% |
104,178
+4,300
| +4% | +$85.4K |
|
|
AAT
1616
American Assets Trust
AAT
$1.27B
| $2.06M | ﹤0.01% |
61,600
+2,800
| +5% | +$93.5K |
|
|
XOG
1617
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
| $2.06M | ﹤0.01% |
179,500
+7,700
| +4% | +$88.2K |
|
1618
Fabrinet
FN
$12.9B
| $2.05M | ﹤0.01% |
65,440
| – | – |
|
|
WIRE
1619
DELISTED
Encore Wire Corp
WIRE
| $2.05M | ﹤0.01% |
36,233
+1,700
| +5% | +$96.4K |
|
1620
Houlihan Lokey
HLI
$14.5B
| $2.05M | ﹤0.01% |
46,036
+1,100
| +2% | +$49.1K |
|
|
AIMT
1621
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $2.05M | ﹤0.01% |
64,474
+23,900
| +59% | +$761K |
|
1622
Atara Biotherapeutics
ATRA
$87M
| $2.05M | ﹤0.01% |
2,104
+960
| +84% | +$936K |
|
|
RDUS
1623
DELISTED
Radius Health, Inc.
RDUS
| $2.05M | ﹤0.01% |
57,000
+3,000
| +6% | +$108K |
|
|
MDC
1624
DELISTED
M.D.C. Holdings, Inc.
MDC
| $2.05M | ﹤0.01% |
85,578
| – | – |
|
|
BMCH
1625
DELISTED
BMC Stock Holdings, Inc
BMCH
| $2.04M | ﹤0.01% |
104,519
+1,900
| +2% | +$37.1K |
|